Mycobacterial genomes contain large sets of loci encoding membrane proteins that belong to a family of multidrug resistance pumps designated Resistance-Nodulation-Cell Division (RND) permeases. Mycobacterial membrane protein Large (MmpL) transporters represent a subclass of RND transporters known to participate in the export of lipid components across the cell envelope. These surfaceexposed lipids with unusual structures play key roles in the physiology of mycobacteria and/or can act as virulence factors and immunomodulators. Defining the substrate specificity of MmpLs and their mechanisms of regulation helps understanding how mycobacteria elaborate their complex cell wall. This review describes the diversity of MmpL proteins in mycobacteria, emphasising their high abundance in a few opportunistic rapid-growing mycobacteria. It reports the conservation of mmpL loci between Mycobacterium tuberculosis and non-tuberculous mycobacteria, useful in predicting the role of MmpLs with unknown functions. Paradoxically, whereas MmpLs participate in drug resistance mechanisms, they represent also attractive pharmacological targets, opening the way for exciting translational applications. The most recent advances regarding structural/ functional information are also provided to explain the molecular basis underlying the proton-motive force driven lipid transport. Overall, this review emphasises the Janus-face nature of MmpLs at the crossroads between antibiotic resistance mechanisms and exquisite vulnerability to drugs.
Introduction
Efflux pumps are membrane proteins that actively transport a wide array of compounds across the bacterial envelope and are classified into distinct superfamilies (Li et al., 2015) : the ATP-binding cassette (ABC), major facilitator superfamily (MFS), small multidrug resistance (SMR), multidrug and toxic-compound extrusion (MATE) and resistance nodulation cell division (RND) families. MFS, SMR, MATE and RND proteins are typically energised by the proton motive force (PMF). Among the RND superfamily of transporters (Tseng et al., 1999) , the mycobacterial membrane protein Large proteins (MmpL) have emerged during the last few years as key actors in the elaboration of the cell envelope of mycobacteria and the closely related corynebacteria. The genome of Mycobacterium tuberculosis encodes 14 annotated MmpL proteins (Cole et al., 1998) whereas the genome of Corynebacterium glutamicum encodes only four MmpL-like transporters, designated CmpL (Yang et al., 2014) . Consistent with other RND proteins, such as the well-characterised multidrug efflux pump AcrB, the active component of the major efflux system AcrAB-TolC of Escherichia coli (Nikaido and Takatsuka, 2009; Eicher et al., 2014) , the MmpL/CmpL transporters require the inner membrane electrochemical proton gradient for activity as well as predicted topological features (Tseng et al., 1999; Yang et al., 2014; Li et al., 2014; Chim et al., 2015; Bernut et al., 2016) . However, unlike the AcrAB-TolC system that mediates the efflux of exogenous compounds, the MmpL/CmpL proteins essentially appear to export endogenous lipophilic molecules with a relatively narrow substrate specificity (Sz ekely and Cole, 2016; Chalut, 2016) .
Among the MmpL members of M. tuberculosis, MmpL3, involved in the transport of trehalosemonomycolate (TMM), is encoded by the only essential mmpL gene (Grzegorzewicz et al., 2012; Varela et al., 2012; Li et al., 2016; Degiacomi et al., 2017) . MmpL11 coordinates the transport of monomeromycolyl diacylglycerol (MMDAG) and mycolate ester wax (Pacheco et al., 2013) . Both MmpL3 and MmpL11 have also been reported to participate in heme import (Tullius et al., 2011; Owens et al., 2013) . MmpL4 and MmpL5 share redundant functions in siderophore export and are essential for siderophore-mediated iron acquisition (Wells et al., 2013) . MmpL7 mediates the transport of phthiocerol dimycocerosate (PDIM) (Jain and Cox, 2005) whereas MmpL8 transfers the sulfolipid SL-1 to the cell envelope (Converse et al., 2003; Seeliger et al., 2012) . More recently, MmpL10 was reported to participate in the translocation of acylated trehaloses . In comparison with M. tuberculosis, MmpLs in non-tuberculous mycobacteria (NTM) have been given little attention, except for MmpL4a and MmpL4b reported to transport glycopeptidolipids (GPL) to the bacterial surface in Mycobacterium abscessus and Mycobacterium bolletii (Medjahed and Reyrat, 2009; Bernut et al., 2016) . All these unique (glyco)lipids, interspersed in the mycomembrane, contribute to the integrity of the cell envelope, regulate membrane permeability and play important physiological functions, such as defining the shape of the bacilli. By providing mechanical and osmotic protection, these lipids participate in mycobacterial pathogenesis (Jackson, 2014) . Therefore, due to the proper localisation of these lipids in the membrane, their transport by MmpLs is crucial for full expression of virulence in pathogenic mycobacteria. Consequently, the MmpL-driven transport can be viewed as a crucial process, outlining the MmpL transporters as potential important virulence factors. Indeed, disruption of several mmpL genes in M. tuberculosis (mmpL4, mmpL5, mmpL7, mmpL8, mmpL10 and mmpL11) led to significant growth attenuation in mice (Converse et al., 2003; Lamichhane et al., 2005; Domenech et al., 2005) .
Besides being involved in the elaboration of the complex cell envelope, a few MmpL proteins, such as MmpL5, have been shown to participate in the active efflux of antitubercular drugs, including the recently approved drug bedaquiline (Hartkoorn et al., 2014) . As orthologs of mmpL genes were recently identified and characterised in NTM, especially in M. abscessus, notorious for being extremely resistant to most antibiotics and antitubercular drugs (Medjahed et al., 2010; Nessar et al., 2012) , the idea that MmpL efflux pumps may contribute to the multi-drug resistance phenotype in these species has recently emerged. Paradoxically, whereas some MmpL members participate in drug resistance mechanisms, others like MmpL3, are particularly vulnerable to the action of several antitubercular agents identified in whole cell-based screens (Bailo et al., 2015) . MmpL3 is currently considered as a valid pharmacological target leading to intense research dedicated to provide mechanistic and structural information to understand the ability of MmpL proteins to transduce the PMF into transport activity (Grzegorzewicz et al., 2012; Li et al., 2014; Chim et al., 2015; Bernut et al., 2016) . Recently, structural studies using MmpL3, MmpL11 or MmpL4a as prototypes led to important insights into functional aspects of MmpL transporters, unravelling the structural foundations required for the rational design of novel or improved antimycobacterial agents targeting these MmpLs.
The functional role of the MmpLs with respect to their lipid substrates in building the complex cell wall has been the focus of several excellent recent reviews (Sz ekely and Cole, 2016; Chalut, 2016) and will thus not be presented in this article. As being mainly studied in M. tuberculosis, MmpL transporters in NTM have only recently started to receive attention, in spite of their overrepresentation, particularly in rapid-growing mycobacteria (RGM). Therefore, this review focuses on a comparative analysis of the MmpL proteins between slow-growing mycobacteria (SGM) and RGM. Special attention is also given to the recent advances made in understanding their regulation as well as their contribution in drug resistance phenotypes. Data shedding new light on MmpL structure and mechanism of transport described in M. tuberculosis and M. abscessus are also discussed. Finally, a description of the potential of MmpL proteins as attractive drug targets for future drug developments against mycobacterial infections will be presented.
Abundance of MmpL proteins in slow-and rapid-growing mycobacteria
MmpLs belong to the RND permeases superfamily on the basis of topological features, amino acid sequences and functional domains. M. tuberculosis MmpLs are classified into the subgroups of hydrophobic/amphiphilic efflux (HAE) family 2 (corresponding to RND family 5) and HAE family 3 (corresponding to RND family 7) (Sandhu and Akhter, 2015) . All MmpL proteins contain an MmpL domain as defined by the Hidden Markov Model (HMM) profile from the Pfam database (Finn et al., 2014) . However, the mycobacterial MmpL architecture domains are complex, with more than 10 additional domains found in association with the MmpL domain according to the InterProScan database (Mitchell et al., 2015) . The variation in length and position of the MmpL domain results in a high level of architecture diversity among these proteins. The current HMM profile provided by the Pfam database is built on thousands of sequences from different genera. Consequently, it does not reflect the specific diversity in mycobacteria. Therefore, to compare the MmpL abundance among different mycobacterial species, an HMM representative of mycobacterial MmpL proteins was built, allowing the identification of MmpL proteins in 108 mycobacterial strains. The mean number of MmpL per species is depicted on a maximum-likelihood phylogenetic tree constructed with 61 out of the 76 species used in the current study (Fig. 1) . The MmpL mean number per strain ranged from 5 to 29. A striking observation was that a higher number of MmpLs were found in the RGM group when compared with the SGM group (19 6 5 and 14 6 5, respectively). Notably, Mycobacterium leprae presented less MmpLs than the SGM group with five MmpLs on average, probably linked to the phenomenon of gene reduction that occurred in the genome of this mycobacterium due to its obligate intracellular lifestyle (Cole et al., 2001) . Inside the RGM, M. abscessus, Mycobacterium fortuitum and Mycobacterium smegmatis monophyletic groups (or clades) form a superclade corresponding to a 'hot spot' of MmpL abundance (Fig.  1) . Indeed, the M. abscessus clade presented the highest number of MmpLs per RGM strain (27 6 2). The M. fortuitum clade also had more MmpLs than most RGM (23 6 2). In addition, when removing the M. abscessus clade from the RGM group, the RGM MmpL numbers decreased from 19 6 5 to 176 4. However, only the removal of both M. abscessus and M. fortuitum clades from the RGM group brought the RGM MmpL number to that of the SGM group (16 6 3), proving that these two clades are the source of MmpL diversity in RGM. Deciphering the function of these MmpLs might unravel unique aspects of the M. abscessus and M. fortuitum physiology and/or lifestyle.
In fact, the role of MmpLs in virulence has recently been emphasised for some M. abscessus strains (Bernut et al., 2014 . From a functional perspective, the particularly high abundance of MmpLs in M. abscessus might provide the bacterium with some physiological advantage through increased gene dosage of MmpLs performing similar functions. Alternatively, this advantage might be related to diversity in function: aside from their well-known potential role in lipid transport, MmpLs might mediate the uptake of deprived nutrients or extrude toxic compounds in a hostile environment like the macrophage phagosome. A focus on MmpL genomic loci in M. abscessus (10 genes upstream/ downstream MmpL protein-coding genes) sheds some light. Polyketide synthase (PKS) encoding genes, known to play a key role in cell-wall lipid biogenesis (Quadri, 2014) , were found within 4 mmpL loci. Fifteen loci contained more than 2 proteins belonging to Cluster of Orthologous Groups (COG) (Tatusov et al., 2000) M (Cell wall/membrane/envelope biogenesis) and I (Lipid transport and metabolism), 7 contained less than 2 proteins belonging to COG M or I, and 5 did not contain any proteins implicated in cell wall biogenesis or lipid metabolism in general. In M. tuberculosis, all MmpLs proven to be implicated in lipid transport and/or biosynthesis are near to a PKS (Chalut, 2016) . In M. abscessus, MmpL loci do not contain more PKS than M. tuberculosis MmpLs loci, suggesting that M. abscessus MmpLs may also perform other functions than lipid transport.
It is believed that MmpL transporters are likely to work in tight association with accessory partners that modulate lipid export and/or couple export to biosynthesis. However, it remains to be explored whether mycobacteria possess periplasmic membrane fusion-like proteins (MFP) and channel-forming outer-membrane factors (OMF) that, together with MmpL transporters, constitute tripartite transport systems that allow extrusion of substrates through the inner and outer membranes similar to Gram-negative bacteria (Nikaido and Takatsuka, 2009 ). In the case of MmpL3, the export of TMM is dependent on the action of the essential TmaT mycolyl acetyltransferase (Yamaryo-Botte et al., 2015) ( Fig. 2A) . MmpS proteins display no similarity to membrane fusion proteins of Gram-negative bacteria. However, the close association of mmpS and mmpL genes suggests that MmpS proteins may fulfil the role of MFPs (Deshayes et al., 2010; Wells et al., 2013) . GPL export, for instance, involves two MmpL proteins (MmpL4a and MmpL4b) whose activities are regulated by MmpS4 and by an integral membrane protein (Gap) (Sond en et al., 2005) , a transport system that shares similarities with the siderophore export system of M. tuberculosis (Fig.  2B) . Interestingly, MmpL multiplication goes along with that of MmpS. Of note, 24 MmpS-coding genes, identified using a custom HMM MmpS profile built in a similar fashion to our HMM MmpL profile, are found in M. abscessus among which 20 genes are near to mmpL genes. Thus, whatever the nature of the substrate (lipids, metals, toxic compounds), the genomic context suggests that MmpL-mediated transports might be seconded by MmpS proteins.
Localisation of MmpL clusters and functional conservation
An interesting genetic aspect of MmpLs is that the genes encoding the enzymes and the MmpLs involved respectively in the biosynthesis and export of a lipid are MmpL structure and diversity in mycobacteria 891 frequently found in dense clusters. These clusters are often conserved in synteny among the mycobacterial species. Here we show this synteny between a phylogenetically disparate set of model mycobacteria (M. tuberculosis, M. leprae, M. avium, M. marinum, M. abscessus and M. smegmatis) for which well curated and fully annotated whole genome sequences are available and for which experimental data with regards to (Mignard and Flandrois, 2008) , the phylogeny of 61 mycobacterial species was inferred by PHYML and aLRT (Guindon and Gascuel, 2003) . The tree was rooted with Nocardia farcinica. The aLRT statistic values over 0.5 are indicated at each node. Bar, 0.1 estimated nucleotide substitutions per site. RGM: rapid-growing mycobacteria. SGM: slow-growing mycobacteria. MmpL proteins were identified using an HMM profile built with a seed of 35 mycobacterial sequences representative of mycobacterial MmpL proteins. The mean number of MmpL is displayed next to each corresponding species. A scale of MmpL abundance is depicted, which points out a 'hot spot' in the M. abscessus-M. fortuitum-M. smegmatis superclade. their lipid profiles have been generated (Fig. 3) . The well characterised GPL and trehalose polyphleate (TPP) biosynthesis and transport gene clusters are found next to each other in M. smegmatis (Burbaud et al., 2016) . Orthologs of many of the genes within these clusters, including genes involved in the biosynthesis of GPL (rmlA, gft1 and mps) (Billman-Jacobe et al., 1999; Miyamoto et al., 2006; Ripoll et al., 2007) or of TPP (pks and fadD23) (Burbaud et al., 2016) can be found in M. tuberculosis, M. avium, M. leprae and M. marinum that do not produce either GPL or TPP. However, these genes are spread throughout the genomes of these mycobacteria (Fig. 3A) . On the contrary, in M. abscessus and M. avium, both known to elaborate GPL and TPP (Burbaud et al., 2016) , the corresponding gpl and tpp gene clusters are conserved colinearly. Interestingly, the M. abscessus chromosome contains an additional GPL-like cluster, which contains two non-ribosomal peptide synthase-encoding genes, MAB_4690c and MAB_4691c (cognate to mps1 and mps2), the MbtH-like proteinencoding gplH gene, which is essential for GPL synthesis (Tatham et al., 2012) , the D-allo-threonine 6-deoxytalosyltransferase-encoding gene gft1, mmpS4 and two mmpL4 homologues (Ripoll et al., 2009) . While most of the elements of the M. abscessus GPL-related gene cluster have been validated for their role in GPL synthesis or export (Pang et al., 2013) , the contribution of the second and reduced GPL cluster in lipid biosynthesis in this organism remains undetermined. Similar to the GPL cluster, the large cluster of genes responsible for phthiocerol dimycoserosate (PDIM) and phenolic glycolipid (PGL) synthesis in M. tuberculosis is syntenic to the corresponding loci in M. leprae and M. marinum, which also elaborate PDIM and PGL. Orthologs of the genes tesA that encodes a type II thioesterase, fadD26 encoding a fatty acid AMP-ligase and mas encoding a mycocerosic acid synthase, all proven to be necessary for PDIM synthesis (Alibaud et al., 2011; Yu et al., 2012) , are spread throughout the chromosomes of M. abscessus, M. avium and M. smegmatis (Fig. 3B ). The splitting of this specific cluster might explain the absence of PDIM and PGL in these species. Interestingly, a cluster of at least 7 genes including the essential mmpL3 gene and mmpL11 gene are conserved in synteny among all mycobacteria investigated (Fig. 3C ). The strict conservation of mmpL3 in all species was anticipated as this gene has been shown to be essential in M. tuberculosis and M. smegmatis, also due to its role in the transport of mycolic acids, which are crucial components of the mycomembrane (Domenech et al., 2005; Grzegorzewicz et al., 2012; Varela et al., 2012) . In the heme import system, of which both MmpL3 and MmpL11 are thought to be constituents (Owens et al., 2013) , the secreted protein encoded by Rv0203, a gene found just downstream of mmpL11, transports heme across the periplasm to the periplasmic domains of MmpL3 and MmpL11. Another gene located in the highly conserved mmpL3-mmpL11 synteny block and encoding a putative acetyltransferase (Rv0228) has been shown to acetylate TMM as a prerequisite to TMM transport (Yamaryo-Botte et al., 2015; Belardinelli et al., 2016) . However, genes encoding the Pks13 involved in the biosynthesis of TMM (Gavalda et al., 2014) and/or involved in the synthesis of MMDAG are not found in the mmpL3/11 cluster.
While all of the MmpLs that have been discussed in this section so far are implicated in the biosynthesis and or export of cell wall lipids, no lipid substrates have been identified for MmpL4 and MmpL5, which, along with their MmpS partners, transport the siderophores, mycobactin and carboxymycobactin (Chavadi et al., 2011; Wells et al., 2013) . It is noteworthy that mbt1 and A. TMM is first acetylated by the integral membrane protein TmaT to generate AcTMM which is exported to the periplasmic space by MmpL3, probably deacylated in the periplasm by an unknown enzyme to form TMM. The latter is then routed to the Ag85 complex that is associated with the mycomembrane by a yet unknown transport system consisting of proteins sharing similar functions with the membrane fusion-like proteins (MFP) and a channel-forming outer-membrane factor (OMF), to reconstitute a tripartite transport system. The Ag85ABC complex metabolises TMM into biologically active TDM and catalyses the mycolylation of arabinogalactan of the mAGP complex, thereby contributing to the elaboration of the mycomembrane. MmpL3 has also been implicated in heme import. B. In M. smegmatis or M. abscessus, GPL are transported by MmpL4a and MmpL4b which require also MmpS4, acting as a scaffold with MmpL4 proteins for the assembly of the GPL biosynthesis megacomplex. This complex involves also a small integral membrane protein named Gap (GPL addressing protein) that is specifically required for the transport of the GPLs to the mycobacterial surface. The presence of an OMF remains speculative.
mbt2, which encode the enzymes that synthesise mycobactin and carboxymycobactin, are located distantly on the chromosome from both mmpL4 and mmpL5. In addition, mmpL4 and mmpL5 themselves are separated by about 200 kilobases. A syntenic conservation of the two MmpLs involved in siderophore transport along with the siderophore biosynthetic genes is thus not likely between different mycobacteria. However, the mmpS Fig. 3 . Syntenic conservation of the mmpL-containing gene clusters in mycobacteria. The SyMAP 4.2 software, a synteny mapping and analysis program, was used to visualise filtered anchors (corresponding elements) between a particular mmpL-containing gene cluster in a reference genome and the full length subject genome (Soderlund et al., 2011) . A. Synteny of the GPL and TPP clusters of M. smegmatis (MSMEG) with the corresponding clusters in M. abscessus (MAB) and M. avium (MAV). No co-linear conservation of the genes in these clusters of M. smegmatis is seen in the M. leprae (ML), M. marinum (MMAR) or M. tuberculosis H37Rv (Rv) chromosomes. The GPL and TPP clusters within the MAB and MAV chromosomes are indicated with a small, green and blue box respectively. B. Synteny of the PDIM and PGL cluster of M. tuberculosis H37Rv with the corresponding clusters in ML and MMAR. No syntenic conservation of the genes in this cluster of H37Rv is seen in the MAB, MAV or MSMEG chromosomes. C. Synteny of the mmpL3-mmpL11 cluster of H37Rv with the corresponding clusters in all other mycobacterial chromosomes interrogated. D. mmpS4 and a transcriptional regulator-encoding gene, Rv0452 near to M. tuberculosis mmpL4 are co-linearly conserved in other mycobacteria. E. mmpS5 is co-linearly conserved with M. tuberculosis mmpL5 in all investigated mycobacteria, except M. leprae in which the mmpL4 gene exhibits some low-level homology to the mmpL5 of M. tuberculosis. F. Syntenic conservation in mycobacteria of the mmpL13 gene cluster. The lines in red within gene clusters represent mmpL genes in A-F. Panels in green highlight gene clusters involved in the biosynthesis and export of lipids, those in blue gene clusters involved in siderophore export and the panel in light red represents a gene cluster containing an mmpL for which the function is unsolved.
that precedes the mmpL4 as well as a gene encoding a transcriptional regulator preceding mmpS4 appears to be conserved in synteny between all mycobacteria (Fig.  3D) . Similarly, mmpS5 is highly conserved in synteny along with mmpL5 (Fig. 3E ), but the gene that precedes mmpS5, Rv0678 encoding a MarR transcriptional regulator was only detected to be conserved co-linearly in M. marinum. However, genes encoding transcriptional regulators of the TetR family and bearing low protein identity (< 25%) to MarR can be found upstream of mmpS5 in M. abscessus, M. smegmatis and M. avium.
The fact that several MmpL-coding genes appear to localise in gene clusters dedicated to the same biological function might suggest that applying this type of synteny analysis may help us sift the MmpL with likely functions in lipid transport out from the large number of MmpL with unknown functions. This would especially be helpful in genetic studies of virulent species like M. avium, M. ulcerans or M. abscessus containing at least 14, 16 and 27 mmpL genes each, most of which have no known function. Although they are probably neither important for survival nor for virulence in M. tuberculosis, the functions of MmpL1, 2, 6, 9, 12 and 13 have not yet been determined. Interestingly, the mmpL13 gene is truncated in M. tuberculosis H37Rv resulting in two open reading frames, mmpL13a and mmpL13b, in an operon configuration (Fig. 3F) . Because of this truncation, it is generally considered that the two products would be non-functional. In a mexB mutant of Pseudomonas aeruginosa, it was demonstrated that the presence of both amino-and carboxyl-halves of MexB in a complex is essential for transport activity (Eda et al., 2003) . Strikingly, the mmpL13a/mmpL13b operon is conserved as a single open reading frame encoding a protein with 12 transmembrane domains in M. abscessus, M. smegmatis, M. marinum and in M. avium. In addition, a large number of genes in the close proximity to mmpL13 in M. tuberculosis are conserved in synteny between the six mycobacterial genomes investigated, except for M. leprae in which no functional mmpL13 gene is present (Fig. 3F) . The relatively close vicinity of mmpL13a/mmpL13b to pimE and lpqW, elements involved in the synthesis of the more decorated forms of phosphatidylinositol mannoside (PIM) (Crellin et al., 2008; Morita et al., 2006) might suggest a role for this MmpL as the yet unidentified flipase involved in PIM transport across the plasma membrane.
While there may be several possible reasons why some mmpL genes are conserved in syntenic blocks, one appealing explanation is that the close proximity of the mmpL genes to other genes involved in related functions provides a physical advantage to efficiently synthesise and export the lipid substrates, for example their co-localisation may facilitate coordination of expression or complex formation. This has been proposed for the GPL biosynthetic and transport machinery that form a megacomplex, which produces and exports GPL in M. smegmatis (Deshayes et al., 2010) . In agreement with these observations, several studies demonstrated that biosynthesis and MmpL-dependent lipid transport are coupled in mycobacteria (Converse et al., 2003; Jain and Cox, 2005) .
Proton motive force-driven transport enacted by MmpL proteins
Recent bioinformatic analyses along with electron microscopy studies have led to new knowledge with respect to the potential secondary, three-dimensional and quaternary structures of MmpL proteins. All MmpL members are predicted to possess eleven or twelve transmembrane (TM) helices (with the exception of MmpL6 and MmpL13 in M. tuberculosis) where the first five/six transmembrane helices form the first N-terminal domain and the last six helices constitute the Cterminus (Sandhu and Akhter, 2015) (Fig. 4A ). These two domains are separated by a single cytoplasmic helix between TM6 and TM7 that is orientated in parallel to the plasma membrane, in agreement with other RND protein structures. Additionally, two periplasmic domains, designated the porter domains, are located between TM1 and TM2 and between TM7 and TM8 respectively (Chim et al., 2015) . Chim et al. proposed the subdivision of M. tuberculosis MmpLs into two clusters: (i) Cluster I grouping the vast majority of MmpL members, comprising only D1/PN (PN stands for N-terminal porter domain) and PC1/DC/PC2 (PC stands for C-terminal porter domain) and (ii) cluster II consisting of MmpL3/ 11/13 possessing an extra cytoplasmic D3 domain (Chim et al., 2015) (Fig. 4A) . The crystal structure of the periplasmic D2 domain of MmpL11 has recently been solved at very high resolution (Fig. 4B) , emphasising the structural resemblance with other RND porter domains (Chim et al., 2015) , and leading the authors to propose the involvement of D1 and D2 in substrate binding (Tullius et al., 2011) . Domain D3 is predicted to be mainly unstructured in MmpL3 but to adopt a more folded and helical structure in MmpL11. While the role of domain D3 has not yet been uncovered, its cytoplasmic localisation was supported by recent studies on MmpL3 localisation (Carel et al., 2014) . Moreover, deletion of D3 failed to alter TMM translocation activity, suggesting that it is dispensable for the transport activity of MmpL3 (Belardinelli et al., 2016) . That this extra domain is absent in MmpL3 of corynebacteria also questions its functional relevance and contribution in TMM transport. Several independent studies reported homology modelling of MmpL proteins (Chim et al., 2015; Akhter, 2015, 2016; Bernut et al., 2016) (Fig. 4C and  4D ), built despite very low sequence homology to the RND with available crystal structures. All these models propose that, as found in other RND proteins, MmpL transporters might be organised as homotrimers (Fig.  4D) . Although care should be taken regarding the interpretation and use of these modelled three-dimensional structures, they have been very helpful to predict essential residues participating in the proton relay in MmpL3 and MmpL4a . Functional complementation studies of a M. smegmatis mmpL3 conditional mutant (Varela et al., 2012) with various M. tuberculosis mmpL3 alleles demonstrated the essential role of ultraconserved residues, such as the Asp251 in TM4 or the Asp640/Tyr641 pair in TM10, for the MmpL3 activity (Belardinelli et al., 2016; Bernut et al., 2016) (Fig. 4E) . Additionally, using a similar approach Asp710 and Arg715 in TM12 have been shown to be crucial elements for TMM transport (Belardinelli et al., 2016) . Although the direct role of these amino acids in the PMF still awaits experimental proof, it is certainly conceivable that these residues could convey protons, supported by the analogy with the residues from TM4, TM10 and TM12 that are critical for the proton relay of E. coli AcrB (Su et al., 2006; Eicher et al., 2014) . Recently, a single particle electron microscopy study unravelled the first low-resolution (18Å ) three-dimensional structure of MmpL3 (CmpL1) from C. glutamicum (Belardinelli et al., 2016) . The electron density clearly attested to a trimeric symmetry shape, confirming the homotrimeric architecture of the transporter. This structure exhibits a central vestibule on the three-fold axis accessible from both the cytoplasmic and periplasmic sides and filled with hydrophobic residues, presumably enabling the channelling of host lipids such as TMM. Additionally, a crevice defined by the TM regions brought by the different subunits has also been proposed as a potential path for TMM (Belardinelli et al., 2016) .
The so far well-described bacterial RND proteins are those involved in the transport/efflux of small molecules such as metal ions or antibiotics. Therefore, the transport from the cytoplasm toward the outer membrane of GPL/TMM/PDIM, which are much larger and hydrophobic molecules, remains difficult to envision. All RND proteins work in complex with soluble and outer membrane embedded proteins, such as AcrAB-TolC (Anes et al., 2015) . It is very likely that additional partners may intervene in the transport/flipping mechanism of these very large substrates. It has been shown that TMM acetylation by the TmaT acetyltransferase is essential for its transport in C. glutamicum (Yamaryo-Botte et al., 2015) and M. smegmatis (Belardinelli et al., 2016) . TmaT, being a membrane protein, might synergistically contribute along with MmpL3 to the TMM transport mechanism. Strikingly, the M. tuberculosis MmpL7 PDIM transporter lacks the ultra-conserved Asp/Tyr pairs in TM4 and Asp in TM10 and might therefore not be functional on its own, but might perform its activity along with the LppX lipoprotein and the DrrABC transporter (Cox et al., 1999) , believed to promote PDIM translocation through the plasma membrane. The respective contribution of these proteins in the transport remains to be clarified.
Regulation of MmpL expression
The survival strategies developed by pathogenic mycobacteria are strongly linked to the presence of an unusual cell envelope (Daff e and Draper, 1998) and in response to environmental changes, M. tuberculosis activates or represses the expression of key genes to promptly adjust to new conditions (Schnappinger et al., 2003) . Cell wall biosynthesis and remodelling are important functions for M. tuberculosis to establish and maintain infection. This implies a subtle control of expression of cell wall biosynthetic enzymes and transporters. Distinct mechanisms have been incriminated in the regulation of MmpL expression/activity, either at a transcriptional or at a post-translational level.
The MarR-like transcriptional regulator-coding gene Rv0678 is adjacent to, and downstream of the mmpS5-mmpL5 operon in M. tuberculosis. The crystal structure of Rv0678 revealed a structure similar to members of the MarR family of proteins. Unexpectedly, the structure was solved in complex with a 2-stearoylglycerol molecule, suggesting that this lipid is a natural substrate of the regulator (Radhakrishnan et al., 2014) . Biochemical studies indicated a direct binding of Rv0678 within the intergenic regions between mmpS5 and Rv0678, consistent with a previous finding reporting altered mmpS5-mmpL5 gene expression in strains carrying mutations in Rv0678 (Milano et al., 2009) . Moreover, direct binding of Rv0678 was also found within the promoter regions of mmpS2-mmpL2, mmpS4-mmpL4 and Rv0991-Rv0992. The addition of an isomer of 2-stearoylglycerol reduced the binding of Rv0678 to a target promoter probe, thus confirming that in the presence of this lipid, Rv0678 is unable to bind to its DNA target (Radhakrishnan et al., 2014) .
Among their wide range of cellular activities, including osmotic stress, homeostasis, biosynthesis of antibiotics, virulence and pathogenicity of bacteria, TetR regulators are also known to modulate the expression level of multidrug resistance efflux pumps. The crystallographic structures of two other regulators, Rv3249c and Rv1816, unravelled dimeric two-domain proteins with an architecture related to those of TetR family members (Delmar et al., 2015) . Both proteins were co-crystallised with saturated fatty acids, palmitic acid for Rv3249c and an isopropyl lauric acid for Rv1816, which may represent natural ligands of these regulators. Purified Rv3249c could bind directly to the promoter regions of mmpS1 and mmpL3 and to an intragenic region of mmpL11 (Delmar et al., 2015) . Interestingly, the presence of a palmitic acid molecule buried within Rv3249c, that appears incompatible with binding of the protein to its cognate DNA ligand, was confirmed. Indeed, the addition of the fatty acid reduced the DNA binding activity of Rv3249c. Similarly, purified Rv1816 was found to directly bind to mmpL3, mmpL11 and to a lesser extent mmpL7 probes. Overall, these studies demonstrated a direct binding of several transcriptional regulators to the mmpL intragenic and promoter regions, providing evidence for a transcriptional control of mmpS/mmpL expression. They also highlight that mmpL genes expression is dependent on a complex interplay involving multiple transcription regulators and that ligand binding by Rv0678, Rv3249c and Rv1816 can make these regulators incompatible with their corresponding cognate DNA targets leading to derepression.
Protein phosphorylation/dephosphorylation represents a central mechanism for transduction of specific signals to various cellular processes, such as regulation of growth, differentiation, mobility and survival. Signalling through Ser/Thr phosphorylation has recently emerged as a critical regulatory mechanism in prokaryotes. This is particularly true in M. tuberculosis, which possesses a large family of eukaryotic-like Ser/Thr protein kinases (STPKs) (Av-Gay and Everett, 2000) . During the last decade, multiple mycobacterial STPK substrates, connected to cell shape/division and cell envelope biosynthesis, have been identified and the role of Ser/Thr phosphorylation by STPK in regulating important cell wall biosynthetic pathways has been delineated (Molle and Kremer, 2010) . Using an M. tuberculosis mutant lacking the kinase domain of the PknD kinase, MmpL7 was identified as an endogenous phosphorylated substrate (P erez et al., 2006) . This suggests that phosphorylation of MmpL7, and perhaps other MmpLs, could regulate the deposition of cell wall-associated glycolipids to the cell membrane.
MmpL proteins involved in drug resistance mechanisms
In their initial study, Domenech et al. were able to inactivate 11 out of the 12 complete mmpL genes in M. tuberculosis H37Rv and each mutant was assessed for growth kinetics and lethality in a murine model for tuberculosis (Domenech et al., 2005) . While four mutants were found to be impaired in one or both measures of virulence (mmpL4, mmpL7, mmpL8 and mmpL11), none of these mutants were affected in their susceptibility/resistance profile to antitubercular drugs, including the first-line drugs isoniazid (INH), ethambutol, rifampicin and pyrazinamide as well as other drugs known to be efflux substrates for RND proteins from other organisms (Domenech et al., 2005) . Although these results suggested that MmpL proteins do not contribute significantly to innate drug resistance in M. tuberculosis, mmpL7 conferred resistance to INH when overexpressed in M. smegmatis (Pasca et al., 2005) . The INH resistance level decreased in the presence of efflux pump inhibitors like reserpine and carbonyl cyanide m-chlorophenylhydrazone (CCCP). INH efflux from M. smegmatis expressing mmpL7 was found to be an energy-dependent process (Pasca et al., 2005) . In an independent study, it was found that efflux inhibitors such as verapamil increased INH sensitivity in INHresistant strains exhibiting up-regulation of various efflux pump genes such as efpA and mmpL7 (Rodrigues et al., 2012) . Moreover, studies on the antileprosy drug clofazimine, of particular interest for the treatment of multidrug-resistant tuberculosis (MDR-TB), has led to the generation of clofazimine-resistant M. tuberculosis mutants carrying mutations in the transcriptional regulator Rv0678, the transcriptional repressor of MmpL5, also designated MmpR5 for mycobacterial membrane protein repressor 5 (Zhang et al., 2015) . These mutations were associated with the concomitant upregulation of mmpL5 and accounted not only for the increased efflux of clofazimine but also of bedaquiline (Andries et al., 2014; Hartkoorn et al., 2014) , the first drug to be approved in decades for the treatment of MDR-TB. Numerous mutations in Rv0678 (Fig. 5A ) were found to lead to derepression of the mmpS5-mmpL5 operon with subsequent transcriptional gene upregulation of mmpS5 and mmpL5, resulting in resistance to azoles through the active efflux of these compounds by MmpL5 (Milano et al., 2009) . This indicates that clofazimine and bedaquiline may also be substrates for this multi-substrate efflux pump. This hypothesis was also supported by data demonstrating that general inhibitors of efflux, verapamil and reserpine, potentiate bedaquiline activity in M. tuberculosis. An interesting observation is the absence of the Rv0678-mmpS5-mmpL5 locus in M. leprae (Fig. 3E) , which may explain why leprosy can be effectively treated with clofazimine, for which resistance was never encountered. Very recent studies also implicated MmpS5/MmpL5-mediated efflux in antibiotic resistance in NTM. Mutations in the mmpT5 encoded TetR repressor located ahead of the mmpS5/mmpL5 operon in Mycobacterium intracellulare were associated with modest resistance levels to bedaquiline and clofazimine (Fig. 5B) (Alexander et al., 2017) . In addition, high resistance levels to a range of thiacetazone derivatives with potent activity against M. abscessus were found in spontaneous resistant mutants harbouring SNPs or indels in the TetR upstream and divergently orientated to one of three putative mmpS5-mmpL5 operons (Fig. 5C ). These mutations in TetR resulted in high induction levels of the mmpS5 and mmpL5 transcripts (Halloum et al., 2017) . Compellingly, over-expression of mmpS5/mmpL5 in these resistant mutants did not result in cross-resistance to any other antibiotics utilised to treat M. abscessus infections, highlighting the specificity toward the compound exported. The presence of two other putative MmpS5/MmpL5-coding operons in M. abscessus (MAB_4311c-MAB_4310c and MAB_4705c-MAB_4704c) may represent resistance mechanisms through efflux of not yet known compounds with anti-M. abscessus activity, or conversely may contribute to the extremely high tolerance exhibited by M. abscessus to a very broad range of antibiotics.
MmpL3 as an attractive antimycobacterial drug target
The essentiality of mmpL3 for growth in axenic media and for establishing infection in human macrophages or in a mouse model was recently demonstrated using conditional knockdown mutants Degiacomi et al., 2017) . Moreover, depletion of MmpL3 had a rapid bactericidal effect and rendered M. tuberculosis more susceptible to MmpL3 inhibitors . In this context, MmpL3 was recently identified in multiple highthroughput whole-cell screens as the target of several antitubercular agents. Currently, it represents one of the most promising antimycobacterial pharmacological targets and numerous chemical entities have recently been shown to inhibit MmpL3 activity not only in M. tuberculosis but also in NTM, thus opening a new field in the inhibition of mycolic acid transport (Grzegorzewicz et al., 2012; La Rosa et al., 2012; Tahlan et al., 2012; Lun et al., 2013; Rao et al., 2013; Bailo et al., 2015; Dupont et al., 2016) . Notably, SQ109, identified in a combinatorial chemistry-based search for ethambutol analogues, currently in phase III of clinical trials, was shown to inhibit MmpL3 in M. tuberculosis (Tahlan et al., 2012) . It was also demonstrated that SQ109 treatment led to inhibition of TDM synthesis and concomitant accumulation of TMM and found that spontaneous SQ109-resitant mutants contained single nucleotide polymorphisms within mmpL3. Shortly thereafter, the pyrrole derivative BM212 (La Rosa et al., 2012) and the adamantyl urea AU1235 (Grzegorzewicz et al., 2012) with antitubercular activity were found to target mmpL3 as resistant mutants harboured mutated mmpL3 alleles. MmpL3 inhibitors act also synergistically with other antitubercular drugs, which is of interest to efforts that aim to reduce the duration of TB treatments (Li et al., 2017) .The divergent scaffolds from which these different inhibitors were derived as well as their broad-spectrum activity against non-mycolate producing bacteria and fungal species, suggested that MmpL3 was probably not the direct target of these inhibitors. Li et al. (2014) have shown that SQ109 causes dissipation of the PMF in M. tuberculosis, thus disrupting MmpL3 function. This uncoupling effect has recently been addressed for several antitubercular drugs targeting MmpL3 (Feng et al., 2015) . In a recent study, tetrahydropyrazo[1,5-a]pyrimidine-3-carboxamide (THPP) was reported to inhibit mycolic acid biosynthesis by targeting the enoylcoenzyme A (CoA) hydratase EchA6, instead of the previously assigned MmpL3 target (Cox et al., 2016) , despite the fact that multiple mutations in mmpL3 conferred resistance to this inhibitor (Remuiñ an et al., 2013) . THPP inhibitors compete with CoA-binding resulting in suppression of mycolic acid synthesis, demonstrating that spontaneous resistance-conferring mutations in mmpL3 can potentially obscure the actual target identification of small inhibitors.
Recently, a new piperidinol-based compound, termed PIPD1, exhibiting potent bactericidal activity against clinical M. abscessus strains was identified. Treatment of M. abscessus-infected zebrafish with PIPD1 correlated with increased embryo survival and decreased bacterial loads . Whole genome analysis of M. abscessus strains resistant to PIPD1 identified several mutations in MAB_4508, encoding a protein homologous to MmpL3. Subsequent biochemical analyses proved that whilst de novo synthesis of mycolic acids remained unaffected by PIPD1 treatment, the compound was found to strongly inhibit the transport of TMM, thereby leading to the inhibition of arabinogalactan mycolylation . In addition, mapping a large panel of distinct mutations conferring resistance to PIPD1 on a MAB_4508/MmpL3 threedimensional homology model allowed identification of a potential PIPD1-binding cavity . Unexpectedly, the residues Val613, Ile616 and Val617 present in TM10, that belong to the putative PIPD1-binding cavity, are also located in the spatial vicinity of the PMF-driven Asp625 and Tyr626 residues in TM10 and whose side chains face the other PMF essential Asp265 residue in TM4 (Fig. 4F) . Binding of PIPD1 may thus destabilise key structural elements and/or arrangements that are required for the proton relay . This may in turn abolish the PMF and the transport of TMM across the membrane, leading to the bactericidal effect of the compound. Overall, this underlines a unique mode of action in M. abscessus, resulting in the arrest of mycolic acid translocation from the cytoplasm, where they are synthesised, to the periplasmic side of the plasma membrane for subsequent use in the formation of the virulence-associated outer membrane trehalosecontaining glycolipids or essential transfer onto the cell wall AG by the Ag85 complex. Of note, the N-benzyl-6 0 ,7 0 -dihydrospiro[piperidine-4,4 0 -thieno[3,2-c]pyran] reported to inhibit MmpL3 in M. tuberculosis (Remuiñ an et al., 2013) is inactive against M. abscessus, indicating that some MmpL3 inhibitors are species-specific. However, the work by Dupont et al. (2016) supports the view of MAB_4508/MmpL3 as a promising drug target to be further exploited against M. abscessus and presumably also against other NTM. Indeed, effective drugs with novel molecular targets are urgently needed to fight these emerging pathogens. The natural resistance of M. abscessus to most commonly available antibiotics seriously limits chemotherapeutic treatment options, which is particularly challenging for treating cystic fibrosis patients infected with this RGM (Nessar et al., 2012) .
Conclusion and future perspectives
An important observation arising from the present analysis is that a higher number of MmpLs is found in the RGM group than in the SGM group, and particularly in the M. abscessus clade. This is corroborated by recent comparative genomic studies indicating that M. abscessus evolves rapidly and continues to acquire new genetic material for the adaptation to divergent environmental conditions (Choo et al., 2014; Sapriel et al., 2016) . The capacity of M. abscessus to transition from a smooth intra-macrophage-resistant form to a rough extracellular form is likely to facilitate its capacity to adapt and survive in the changing environments . In this context, modulation of its cell wall composition/architecture and its ability to extrude toxic xenobiotics prevailing in its various habitats and hosts may also be greatly aided by its high number of MmpL transporters. The consequence of this large network of efflux pumps may explain, at least partly, the intrinsic resistance of M. abscessus to most antimicrobials (Nessar et al., 2012) . However, much remains to be learned regarding the multiple and perhaps untapped functions of the diverse family of proteins in NTM, particularly in apprehending their contribution to the exquisite antibiotic resistance profiles expressed by some NTM.
Important progresses have been made these last few years in functionally and structurally characterising the MmpL proteins involved in the export of surfaceexposed lipids in mycobacteria and corynebacteria. Although these transporters are thought to mediate translocation of the substrates across the plasma membrane using the PMF as a source of energy, important questions remain unaddressed. The description of the proton pathway that energises these transporters is far from being complete and awaits high-resolution structures as well as the development of functional assays. Once achieved, this may also bring further insights to explain the molecular basis of substrate recognition and translocation, how the different inhibitors inhibit MmpL3, and to define whether they have access to the same or different binding cavities. The design of new and improved chemotypes targeting MmpL3 for future antimycobacterial drug developments would greatly benefit from such structural and functional studies. Access to a biochemical assay would undoubtedly be helpful as the MmpL3 inhibitors are distinct pharmacophores, raising the question whether they exert their activity through specific inhibition of the MmpL3 transporter functions or through indirect mechanisms, for example involving the dissipation of the PMF (Li et al., 2014) . The continuing rise of MDR tuberculosis and the emergence of difficultto-treat NTM infections warrant the need for new drugs with new modes of action that will shorten treatment duration. In this regard, MmpL3 inhibitors may have significant potential (Li et al., 2017) . Since the export of TMM requires the action of the essential TmaT mycolyl acyltransferase, MmpL interactors such as TmaT may represent potential drug targets that remain to be explored. Additionally, targeting MmpL binding partners, such as peptides exhibiting anti-virulence functions, may also pave the way toward innovative approaches to combat mycobacterial infections. This view is supported by work demonstrating that overexpression of the mycobacterial KdpF peptide, shown to interact with the transmembrane domains 2-6 of MmpL7 and MmpL10, restricts intramacrophage growth and the ability of mycobacteria to form cords (Gannoun-Zaki et al., 2013) .
